Extensions

Analysis of U.S. Patent 12,186,474

Date of Analysis: April 26, 2026

An analysis of United States Patent 12,186,474, titled "System and method for collecting plasma," has been conducted. The patent is assigned to Haemonetics Corp. Below are the findings regarding its term, related applications, and expiration date.

Patent Term and Expiration:

• Grant Date: January 7, 2025
• Application Number: 17/205,400
• Filing Date: March 18, 2021
• Projected Expiration Date: January 21, 2040

The projected expiration date of January 21, 2040, includes a significant Patent Term Adjustment (PTA). A standard 20-year term from the filing date would have resulted in an expiration date of March 18, 2041. The adjusted date indicates that while there may have been some PTA awarded for delays during prosecution by the USPTO, the controlling date is the 20-year term from the earliest priority date. The patent claims priority to an application filed on May 30, 2017. A twenty-year term from this earlier filing date would be May 30, 2037. The "Adjusted expiration" of January 21, 2040, as listed on the patent documentation, reflects the calculated PTA granted by the USPTO. No Patent Term Extensions (PTE) under 35 U.S.C. § 156 for regulatory review delays were noted.

Continuation and Divisional Applications:

U.S. Patent 12,186,474 is part of a larger family of applications and is a continuation of a prior application. The "PRIORITY" section of the patent text confirms this lineage:

• This application is a continuation of U.S. application Ser. No. 16/931,333, filed July 16, 2020.
• U.S. application Ser. No. 16/931,333 is a continuation of U.S. application Ser. No. 15/793,339 (now U.S. Pat. No. 10,792,416), filed October 25, 2017.
• U.S. application Ser. No. 15/793,339 is a continuation-in-part of U.S. patent application Ser. No. 15/608,183 (now U.S. Pat. No. 10,758,652), filed May 30, 2017.

No divisional applications were identified based on the available information.

Patent Family Members:

The patent is related to several other U.S. patents and patent applications through its priority claims. Key identified family members include:

• U.S. Patent 10,758,652: The original parent application.
• U.S. Patent 10,792,416: An intervening parent application.
• U.S. Patent Application Publication 2021/0205526 A1: The publication of the application that led to patent 12,186,474.

Further national and international family members may exist but are not detailed in the primary record of this specific patent.